Japan's Ajinomoto to buy US-based Forge Biologics for $546 million

Ajinomoto Co

13/11/2023 06:42

TOKYO, Nov 13 (Reuters) - Japan's Ajinomoto  2802.T 
said on Monday it agreed to acquire U.S.-based genetic medicines
maker Forge Biologics Holdings for 82.8 billion yen ($546
million). 
    The transaction is expected to be completed in December 2023
pending regulatory approvals, Ajinomoto said a release. 

    ($1 = 151.7400 yen)

 (Reporting by Mariko Katsumura and Rocky Swift in Tokyo;
Editing by Tom Hogue)
 ((Mariko.Katsumura@thomsonreuters.com;))